Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
RO-7185876 by F. Hoffmann-La Roche for Alzheimer's Disease: Likelihood of Approval
RO-7185876 is under clinical development by F. Hoffmann-La Roche and currently in Phase I for Alzheimer's Disease. According to GlobalData,...